MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

13 Jul 2022 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed a copy of press release regarding - Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize''s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..